Utility of a next-generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposide.

Publication

Utility of a next-generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposide.

Nicolette, John; Luijten, Mirjam; Sasaki, Jennifer C; Custer, Laura; Embry, Michelle; Froetschl, Roland; Johnson, George; Ouedraogo, Gladys; Settivari, Raja; Thybaud, Veronique; Dearfield, Kerry L

Type

Article
Other

Language

en

Date

2021-11-22

Show all metadata

Title

Utility of a next-generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposide.

Published in

Environ Mol Mutagen 2021 ; 62(9):512-25

DOI

10.1002/em.22467

PMID

URI

http://hdl.handle.net/10029/625478

Collections